<p>Part 1. Basic concepts </p><p>Chapter 1. Issues in Translation of Pharmacogenomics into Clinical Practice.</p><p> Kiang-Teck J. Yeo, Nikolina Babic, Alan H.B. Wu</p>Chapter 2. Molecular Diagnostic Methods in Pharmacogenomics<p> Nikolina Babic<sup>*</sup>, Loren J. Joseph, Kiang-Teck J. Yeo</p><p>Chapter 3. Economics of pharmacogenomic testing in clinical practice</p><p> Alan H.B. Wu</p><p>Chapter 4. From Personalized Medicine to Personalized Justice: The Promises of Translational Pharmacogenomics in the Justice System<p>Steven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo.</p><p> </p><p>Part 2. Specific pharmacogenomic targets: Chemotherapeutics</p><p>Chapter 5. Irinotecan</p><p>R. Stephanie Huang, Federico Innocenti and Mark J. Ratain</p><p>Chapter 6. Pharmacogenomics of tamoxifen </p><p>Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman </p><p>Chapter 7. Thiopurines</p><p>Terreia S. Jones, Mary V. Relling</p><p> </p><p>Part 3. Specific pharmacogenomic targets: Cardiovascular drugs</p><p>Chapter 8. The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs</p><p>Charles Eby</p><p>Chapter 9. Clopidogrel and Salicylates</p><p>Janice Y Chyou, Marc S Sabatine</p><p>Chapter 10. DNA-Guided Statin Therapy</p><p>Gualberto Ruaño, Richard L. Seip, Jorge Duconge</p><p>Chapter 11. The statin response gene: Kif6</p><p>....................... H. Robert Superko, Tom White, James Forrester, Spencer King III.</p><p> </p><p>Part 4. Drugs that cause delayed hypersensitivity</p><p>Chapter 12. Abacavir</p><p>Elizabeth J. Phillips, Simon A. Mallal</p><p>Chapter 13. Allopurinol</p><p>Pei Chen, Shuen-Iu Hung, Shih-Yang Chen, Yuan-Tsong Chen<p>Chapter 14. Carbamazepine and its structurally-related antiepiletics</p><p>Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen</p><p>Part 5........ Miscellaneous drugs</p><p>Chapter 15. Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury</p><p>Hong-Kee Lee, Lionel D. Lewis</p><p>Chapter 16. Immunosuppressants Pharmacogenomics </p><p> Ping Wang</p></p></p><p>Steven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo.</p><p> </p><p>Part 2. Specific pharmacogenomic targets: Chemotherapeutics</p><p>Chapter 5. Irinotecan</p><p>R. Stephanie Huang, Federico Innocenti and Mark J. Ratain</p><p>Chapter 6. Pharmacogenomics of tamoxifen </p><p>Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman </p><p>Chapter 7. Thiopurines</p><p>Terreia S. Jones, Mary V. Relling</p><p> </p><p>Part 3. Specific pharmacogenomic targets: Cardiovascular drugs</p><p>Chapter 8. The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs</p><p>Charles Eby</p><p>Chapter 9. Clopidogrel and Salicylates</p><p>Janice Y Chyou, Marc S Sabatine</p><p>Chapter 10. DNA-Guided Statin Therapy</p><p>Gualberto Ruaño, Richard L. Seip, Jorge Duconge</p><p>Chapter 11. The statin response gene: Kif6</p><p>....................... H. Robert Superko, Tom White, James Forrester, Spencer King III.</p><p> </p><p>Part 4. Drugs that cause delayed hypersensitivity</p><p>Chapter12. Abacavir</p><p>Elizabeth J. Phillips, Simon A. Mallal</p><p>Chapter 13. Allopurinol</p><p>Pei Chen, Shuen-Iu Hung, Shih-Yang Chen, Yuan-Tsong Chen<p>Chapter 14. Carbamazepine and its structurally-related antiepiletics</p><p>Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen</p><p>Part 5........ Miscellaneous drugs</p><p>Chapter 15. Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury</p><p>Hong-Kee Lee, Lionel D. Lewis</p><p>Chapter 16. Immunosuppressants Pharmacogenomics </p><p> Ping Wang</p></p><p>Chapter 14. Carbamazepine and its structurally-related antiepiletics</p><p>Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen</p><p>Part 5........ Miscellaneous drugs</p><p>Chapter 15. Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury</p><p>Hong-Kee Lee, Lionel D. Lewis</p><p>Chapter 16. Immunosuppressants Pharmacogenomics </p><p> Ping Wang</p>